135 related articles for article (PubMed ID: 8341285)
1. Cellular recognition and HLA restriction of a midsequence HBsAg peptide in hepatitis B vaccinated individuals.
Deulofeut H; Iglesias A; Mikael N; Bing DH; Awdeh Z; Yunis J; Marcus-Bagley D; Kruskall MS; Alper CA; Yunis EJ
Mol Immunol; 1993 Jul; 30(10):941-8. PubMed ID: 8341285
[TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.
Desombere I; Gijbels Y; Verwulgen A; Leroux-Roels G
Clin Exp Immunol; 2000 Dec; 122(3):390-9. PubMed ID: 11122245
[TBL] [Abstract][Full Text] [Related]
4. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.
Leroux-Roels G; Van Hecke E; Michielsen W; Voet P; Hauser P; Pêtre J
Vaccine; 1994 Jul; 12(9):812-8. PubMed ID: 7975860
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.
Kruger A; Adams P; Hammer J; Böcher WO; Schneider PM; Rittner C; Hoehler T
Clin Exp Immunol; 2005 May; 140(2):325-32. PubMed ID: 15807858
[TBL] [Abstract][Full Text] [Related]
6. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
[TBL] [Abstract][Full Text] [Related]
8. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
9. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients.
Schuenke KW; Cook RG; Rich RR
Hum Immunol; 1998 Dec; 59(12):783-93. PubMed ID: 9831134
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immune responses to a native viral antigen and a synthetic peptide derived from it: implications for vaccine development.
Kumar A; Kaul S; Manivel V; Rao KV
Vaccine; 1992; 10(12):814-6. PubMed ID: 1280891
[TBL] [Abstract][Full Text] [Related]
11. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
Mishra A; Rao KV; Durgapal H; Manivel V; Panda SK
Immunology; 1993 Jul; 79(3):362-7. PubMed ID: 7691722
[TBL] [Abstract][Full Text] [Related]
12. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
13. [Association of humans leucocitary antigens with humoral nonresponsive to hepatitis B vaccine in chronic hemodialysis patients].
de Sousa Júnior JX; de Monte Neto JT; de Castro JA; de Andrade HM; do Monte SJ
Rev Soc Bras Med Trop; 2004; 37(1):15-7. PubMed ID: 15042175
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.
Clark JR; Bartley K; Jepson CD; Craik V; March JB
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995
[TBL] [Abstract][Full Text] [Related]
15. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
Schirmbeck R; Böhm W; Ando K; Chisari FV; Reimann J
J Virol; 1995 Oct; 69(10):5929-34. PubMed ID: 7666497
[TBL] [Abstract][Full Text] [Related]
16. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells.
Watanabe H; Okumura M; Hirayama K; Sasazuki T
Tissue Antigens; 1990 Aug; 36(2):69-74. PubMed ID: 1702907
[TBL] [Abstract][Full Text] [Related]
17. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
Milich DR; Peterson DL; Leroux-Roels GG; Lerner RA; Chisari FV
J Immunol; 1985 Jun; 134(6):4203-11. PubMed ID: 2580909
[TBL] [Abstract][Full Text] [Related]
18. Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans.
Min WP; Kamikawaji N; Mineta M; Tana T; Kashiwagi S; Sasazuki T
Hum Immunol; 1996 Apr; 46(2):93-9. PubMed ID: 8727207
[TBL] [Abstract][Full Text] [Related]
19. Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination.
Lindemann M; Barsegian V; Siffert W; Ferencik S; Roggendorf M; Grosse-Wilde H
Virology; 2002 Jun; 297(2):245-52. PubMed ID: 12083823
[TBL] [Abstract][Full Text] [Related]
20. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
